Intelligent Ultrasound Group Plc (GB:IUG) has released an update.
Intelligent Ultrasound Group plc has agreed to sell its Clinical AI business to GE HealthCare for £40.5 million, excluding the NeedleTrainer products which will stay within the Simulation Business. Despite a 22% drop in continuing operations revenue in the first half of 2024, driven by market declines in the UK and North America, the company has seen positive growth in reseller sales and NeedleTrainer revenues. The company’s board plans to return capital to shareholders after a strategic review following the sale’s completion.
For further insights into GB:IUG stock, check out TipRanks’ Stock Analysis page.
